Fresenius SE & Co. KGaA (FSNUF)
OTCMKTS
· Delayed Price · Currency is USD
39.00
+2.50 (6.85%)
At close: Feb 14, 2025
Fresenius SE & Co. KGaA Revenue
Fresenius SE & Co. KGaA had revenue of 5.37B EUR in the quarter ending September 30, 2024, with 3.45% growth. This brings the company's revenue in the last twelve months to 22.81B, up 6.79% year-over-year. In the year 2023, Fresenius SE & Co. KGaA had annual revenue of 22.30B with 3.56% growth.
Revenue (ttm)
22.81B EUR
Revenue Growth
+6.79%
P/S Ratio
n/a
Revenue / Employee
117.66K EUR
Employees
193,865
Market Cap
21.48B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 22.30B | 767.00M | 3.56% |
| Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
| Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
| Dec 31, 2020 | 36.28B | 868.00M | 2.45% |
| Dec 31, 2019 | 35.41B | 1.88B | 5.60% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 21.77M |
| BioStem Technologies | 210.49M |
Fresenius SE & Co. KGaA News
- 4 weeks ago - It's clear the old world order has come to an end, says Fresenius CEO - CNBC
- 7 weeks ago - Fresenius: The Signs Of A Significant Turnaround Are Getting Clearer And Clearer - Seeking Alpha
- 2 months ago - Siemens Taps Ex-Nestle CEO Schneider for Board, Potential Chair - BNN Bloomberg
- 3 months ago - DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation - Seeking Alpha
- 3 months ago - Fresenius SE & Co. KGaA (FSNUF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fresenius SE Raises Guidance After Strong Kabi, Helios Performances - The Wall Street Journal
- 3 months ago - Fresenius SE Raises Guidance After Strong Kabi, Helios Performances - WSJ
- 3 months ago - Fresenius SE & Co. reports Q3 results - Seeking Alpha